NCT06031012View on ClinicalTrials.gov

Compound Glutamine Enteric-Coated Capsules Combined with Thalidomide in Preventing Radiation-induced Oral Mucositis

PHASE3RecruitingINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

September 15, 2023

Primary Completion Date

August 31, 2025

Study Completion Date

October 31, 2025

Conditions
Mucositis Oral
Interventions
DRUG

CGECC combined with thalidomide

Patients received glutamine combined with thalidomide from the beginning of radiotherapy to one week after radiotherapy.

DRUG

CGECC alone

Patients received CGECC alone from the beginning of radiotherapy to one week after radiotherapy.

Trial Locations (1)

710032

RECRUITING

Department of Radiation Oncology, Xijing Hospital, Fourth Military Medical University, Xi'an

All Listed Sponsors
lead

Air Force Military Medical University, China

OTHER